Skip to main content
Omega Therapeutics, Inc. (OMGA)
NASDAQ: OMGA · IEX Real-Time Price · USD
2.270
-0.080 (-3.40%)
At close: Apr 26, 2024, 4:00 PM
2.290
+0.020 (0.88%)
After-hours: Apr 26, 2024, 6:52 PM EDT

Omega Therapeutics Revenue

In the year 2023, Omega Therapeutics had annual revenue of $3.09M with 49.25% growth. Revenue in the quarter ending December 31, 2023 was $989.00K with 34.56% year-over-year growth.

Revenue (ttm)
$3.09M
Revenue Growth
+49.25%
P/S Ratio
40.47
Revenue / Employee
$33,269
Employees
93
Market Cap
125.20M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20233.09M1.02M49.25%
Dec 31, 20222.07M1.93M1,339.58%
Dec 31, 2021144.00K--
Dec 31, 20200--
Dec 31, 20190--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
So-Young International 211.29M
Repare Therapeutics 51.13M
Augmedix 44.86M
Zomedica 25.19M
DBV Technologies 15.73M
Molecular Partners AG 8.38M
MSP Recovery 7.71M
Delcath Systems 2.07M
Revenue Rankings

OMGA News

More News